Sadat-Eebrahimi, S., Mirmohammadi, M., Mojallal Tabatabaei, Z., Azimzadeh Arani, M., Jafari-Ashtiani, S., Hashemian, M., Foroumadi, P., Yahya-Meymandi, A., Moghimi, S., Moshafi, M., Norouzi, P., Kabudanian Ardestani, S., Foroumadi, A. (2019). Novel 5-(nitrothiophene-2-yl)-1,3,4-Thiadiazole Derivatives: Synthesis and Antileishmanial Activity against promastigote stage of Leishmania major. Iranian Journal of Pharmaceutical Research, 18(4), 1816-1822. doi: 10.22037/ijpr.2019.14547.12476
Seyed.Esmaeil Sadat-Eebrahimi; Maryam Mirmohammadi; Zahra Mojallal Tabatabaei; Marjan Azimzadeh Arani; Sogol Jafari-Ashtiani; Mahsa Hashemian; Parham Foroumadi; Azadeh Yahya-Meymandi; Setareh Moghimi; Mohammad Hasan Moshafi; Peiman Norouzi; Sussan Kabudanian Ardestani; Alireza Foroumadi. "Novel 5-(nitrothiophene-2-yl)-1,3,4-Thiadiazole Derivatives: Synthesis and Antileishmanial Activity against promastigote stage of Leishmania major". Iranian Journal of Pharmaceutical Research, 18, 4, 2019, 1816-1822. doi: 10.22037/ijpr.2019.14547.12476
Sadat-Eebrahimi, S., Mirmohammadi, M., Mojallal Tabatabaei, Z., Azimzadeh Arani, M., Jafari-Ashtiani, S., Hashemian, M., Foroumadi, P., Yahya-Meymandi, A., Moghimi, S., Moshafi, M., Norouzi, P., Kabudanian Ardestani, S., Foroumadi, A. (2019). 'Novel 5-(nitrothiophene-2-yl)-1,3,4-Thiadiazole Derivatives: Synthesis and Antileishmanial Activity against promastigote stage of Leishmania major', Iranian Journal of Pharmaceutical Research, 18(4), pp. 1816-1822. doi: 10.22037/ijpr.2019.14547.12476
Sadat-Eebrahimi, S., Mirmohammadi, M., Mojallal Tabatabaei, Z., Azimzadeh Arani, M., Jafari-Ashtiani, S., Hashemian, M., Foroumadi, P., Yahya-Meymandi, A., Moghimi, S., Moshafi, M., Norouzi, P., Kabudanian Ardestani, S., Foroumadi, A. Novel 5-(nitrothiophene-2-yl)-1,3,4-Thiadiazole Derivatives: Synthesis and Antileishmanial Activity against promastigote stage of Leishmania major. Iranian Journal of Pharmaceutical Research, 2019; 18(4): 1816-1822. doi: 10.22037/ijpr.2019.14547.12476
Novel 5-(nitrothiophene-2-yl)-1,3,4-Thiadiazole Derivatives: Synthesis and Antileishmanial Activity against promastigote stage of Leishmania major
1Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
2Department of Biochemistry, Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.
3Drug Design and Development Research Center, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran.
4Pharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.
Abstract
In this study, a series of novel compounds based on 5-(5-nitrothiophene-2-yl)-1,3,4-thiadiazole possessing (het)aryl thio pendant at C-2 position of thiadiazole ring is developed and evaluated as antileishmanial agents using MTT colorimetric assay. 10 New compounds containing aryl and hetero aryl derivatives, started from thiophene-2-carbaldehyde in five steps, were synthesized in good to excellent yields and characterized by 1H-NMR, 13C-NMR and IR spectroscopy. Through the compounds 6a-j, methylimidazole containing derivative 6e was recognized as the most active compound against L. major promastigotes exhibiting IC50 values of 11.2µg/ml and 7.1µg/ml after 24 and 48 hours, respectively. This compound is >4 fold more effective than Glucantime as a standard drug (IC50 = 50 µg/ml after 24 h and 25 µg/ml after 48 h).
Top